These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15464917)

  • 1. Somatic cell engineering and the immunotherapy of leukemias and lymphomas.
    Brentjens RJ; Sadelain M
    Adv Pharmacol; 2004; 51():347-70. PubMed ID: 15464917
    [No Abstract]   [Full Text] [Related]  

  • 2. Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.
    Rivière I; Sadelain M
    Mol Ther; 2017 May; 25(5):1117-1124. PubMed ID: 28456379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic engineering of T cells in leukemia and lymphoma.
    Kochenderfer JN
    Clin Adv Hematol Oncol; 2014 Mar; 12(3):190-2. PubMed ID: 24927269
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxic T lymphocytes for leukemia and lymphoma.
    Bollard CM; Barrett AJ
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):565-9. PubMed ID: 25696912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunotherapy of hemato-oncologic diseases].
    Winkler U; Bohlen H; Schirrmacher V; Schlimok G; Voliotis D; Brach M; Niederle N; Tesch H; Diehl V; Engert A
    Med Klin (Munich); 1996 Apr; 91(4):226-33. PubMed ID: 8692109
    [No Abstract]   [Full Text] [Related]  

  • 6. CAR T cell therapy: inroads to response and resistance.
    Brown CE; Mackall CL
    Nat Rev Immunol; 2019 Feb; 19(2):73-74. PubMed ID: 30631206
    [No Abstract]   [Full Text] [Related]  

  • 7. [Monoclonal antibodies for lymphomas and leukemias in 2005].
    Peffault de Latour R; Robin M; Bay JO
    Bull Cancer; 2006 Jan; 93(1):107-18. PubMed ID: 16455513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation against leukemias and lymphomas: a realistic future treatment?
    Mittal S; Marshall NA; Barker RN; Vickers MA
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):101-8. PubMed ID: 17719232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing cancer immunotherapy research in Iran: adoptive cell therapy on the horizon.
    Khatami F; Torabi-Rahvar M; Kiani J; Naderi M; Ahmadbeigi N
    Cytotherapy; 2018 Oct; 20(10):1227-1237. PubMed ID: 30266521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine modulation of the innate immune system in the treatment of leukemia and lymphoma.
    Farag SS; Caligiuri MA
    Adv Pharmacol; 2004; 51():295-318. PubMed ID: 15464915
    [No Abstract]   [Full Text] [Related]  

  • 11. CANCER IMMUNOTHERAPY. Baby's leukemia recedes after novel cell therapy.
    Couzin-Frankel J
    Science; 2015 Nov; 350(6262):731. PubMed ID: 26564829
    [No Abstract]   [Full Text] [Related]  

  • 12. Antileukemia and antitumor effects of the graft-versus-host disease: a new immunovirological approach.
    Sinkovics JG
    Acta Microbiol Immunol Hung; 2010 Dec; 57(4):253-347. PubMed ID: 21183421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of hematologic malignancies in primary immunodeficiency disorders: opportunities for immunotherapy.
    Verhoeven D; Stoppelenburg AJ; Meyer-Wentrup F; Boes M
    Clin Immunol; 2018 May; 190():22-31. PubMed ID: 29499421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor lymphocyte infusions.
    Ho VT; Alyea EP
    Adv Pharmacol; 2004; 51():319-45. PubMed ID: 15464916
    [No Abstract]   [Full Text] [Related]  

  • 15. Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells.
    Cruz CR; Bollard CM
    Curr Drug Targets; 2017; 18(3):271-280. PubMed ID: 26648070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-idiotype antibodies reveal the existence of somatic mutation in human B cell lymphoma.
    Levy R; Levy S; Brown SL; Kon S; Carroll W
    Monogr Allergy; 1987; 22():194-203. PubMed ID: 3325832
    [No Abstract]   [Full Text] [Related]  

  • 17. 9th Symposium on Molecular Biology of Hematopoiesis and Treatment of Leukemias and Lymphomas. Genoa, June 23-27, 1995. Abstracts.
    Acta Haematol; 1995; 93(2-4):113-276. PubMed ID: 7639052
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches.
    Angata T; Nycholat CM; Macauley MS
    Trends Pharmacol Sci; 2015 Oct; 36(10):645-660. PubMed ID: 26435210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCs in lymphoma--biology and therapeutic aspects.
    Schultze JL; Fiore F; von Bergwelt-Baildon M
    Cytotherapy; 2004; 6(2):138-47. PubMed ID: 15203990
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies.
    Nadler LM; Ritz J; Griffin JD; Todd RF; Reinherz EL; Schlossman SF
    Prog Hematol; 1981; 12():187-225. PubMed ID: 7041173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.